Tracking every rollback, reversal, and overreach — and the path back to the America we know.
President Trump invoked the Alien Enemies Act of 1798 on March 14, 2025, designating Tren de Aragua as an invading force threatening U.S. national security. The proclamation authorizes enhanced enforcement actions against members of the Venezuelan gang organization. This significantly expands executive power to detain and remove foreign nationals without standard immigration proceedings.
President Trump signed Executive Order 14236 rescinding additional executive orders and actions from previous administrations. The order reverses policies deemed harmful by the Trump administration. The direct impact includes elimination of specific regulatory frameworks and policy directives affecting federal agencies and potentially American citizens across multiple sectors.
Executive Order 14238 was signed on March 14, 2025, continuing efforts to reduce federal government workforce and agencies. The order implements further reductions in bureaucratic positions and federal employment. The direct impact on Americans includes potential changes to federal services, job losses in government positions, and shifts in regulatory enforcement.
Trump administration extended the national emergency declaration regarding Iran first established in 1995. The continuation allows the president to maintain broad executive powers over Iran-related sanctions and foreign policy actions. Americans may face continued restrictions on Iran trade and increased geopolitical tensions.
Executive Order 14234 was signed on March 7, 2025, establishing a White House Task Force on the FIFA World Cup 2026. The task force coordinates federal, state, and local preparation for the tournament scheduled to be held in the United States. The confirmed direct impact includes designation of federal resources and coordination mechanisms for infrastructure, security, and logistics planning for the event.
On March 7, 2025, President Trump signed Executive Order 14235 to restore the Public Service Loan Forgiveness (PSLF) program. The order reinstates loan forgiveness eligibility for federal employees, teachers, healthcare workers, and other public service workers who meet program requirements. The confirmed direct impact is that eligible borrowers in public service occupations regain access to loan forgiveness after 10 years of qualifying payments.
Executive Order 14232 was signed on March 6, 2025, to address the flow of illicit drugs across the southern border through amendments to existing duties and enforcement procedures. The order modifies enforcement mechanisms and regulatory approaches to combat drug trafficking at the U.S.-Mexico border. Direct impacts include increased border enforcement activities and potential changes to trade and customs operations affecting border communities and commerce.
On March 6, 2025, President Trump signed Executive Order 14233 directing the establishment of a Strategic Bitcoin Reserve and United States Digital Asset Stockpile. The order directs the federal government to acquire and hold Bitcoin and other digital assets as part of national reserves. The confirmed direct impact includes the U.S. government beginning to purchase and accumulate Bitcoin using federal resources, affecting federal asset allocation and budget priorities.
A settlement between President Trump and the IRS expanded a previously agreed $1.8 billion "anti-weaponization" fund to permanently bar the agency from conducting any tax investigations or prosecutions involving Trump, his family, and his businesses. The one-page agreement states the IRS is "forever barred and precluded" from pursuing related claims, raising concerns about selective enforcement and presidential self-dealing.
On March 3, 2025, President Trump signed Executive Order 14228, further amending duties addressing the synthetic opioid supply chain originating from China. The order modifies existing tariff or enforcement mechanisms related to Chinese opioid precursors and related materials. Confirmed direct impacts on Americans include altered costs for pharmaceutical inputs and potential effects on opioid treatment medication availability and pricing.